Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2025)
Top pharmaceutical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...
B
Pharmaceutical is Zen Rated B and is the 38th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Sentiment
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
AMRX
AMNEAL PHARMACEUTICALS INC
$2.40B309,966,34125.22%74.78%Net SellingNet Selling
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.81B55,814,49646.30%53.70%Net SellingNet Selling
PCRX
PACIRA BIOSCIENCES INC
$1.25B46,276,24168.43%31.57%Net Selling
HCM
HUTCHMED (CHINA) LTD
$2.64B871,601,0950.78%0.00%
ORGO
ORGANOGENESIS HOLDINGS INC
$618.92M126,828,0926.08%93.92%Net SellingNet Selling
KMDA
KAMADA LTD
$379.53M57,505,03110.63%0.00%
PAHC
PHIBRO ANIMAL HEALTH CORP
$764.71M40,503,60845.01%54.99%Net BuyingNet Buying
ALKS
ALKERMES PLC
$4.68B162,614,06793.17%6.83%Net SellingNet Selling
ETON
ETON PHARMACEUTICALS INC
$442.22M26,817,53548.98%22.99%Net Buying
PRGO
PERRIGO CO PLC
$3.50B136,458,62062.25%37.75%Net BuyingNet Buying
COLL
COLLEGIUM PHARMACEUTICAL INC
$869.00M31,485,52357.13%42.87%Net SellingNet Selling
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.43B124,070,82965.89%34.11%Net SellingNet Selling
CPIX
CUMBERLAND PHARMACEUTICALS INC
$68.03M13,968,39413.19%59.75%Net BuyingNet Buying
ANIP
ANI PHARMACEUTICALS INC
$1.54B21,773,51028.48%71.52%Net SellingNet Selling
DERM
JOURNEY MEDICAL CORP
$174.21M23,104,43716.36%33.18%Net SellingNet Selling
HLN
HALEON PLC
$46.69B9,083,725,9198.23%0.00%
INDV
INDIVIOR PLC
$1.46B124,655,85862.35%0.00%
SNOA
SONOMA PHARMACEUTICALS INC
$6.38M1,615,7650.52%99.48%
BHC
BAUSCH HEALTH COMPANIES INC
$2.03B367,933,89768.89%30.95%Net SellingNet Selling
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$4.06B49,537,83969.50%30.50%Net SellingNet Selling
EOLS
EVOLUS INC
$735.70M63,586,75374.49%25.51%Net SellingNet Selling
IRWD
IRONWOOD PHARMACEUTICALS INC
$152.10M161,809,43271.80%28.20%Net SellingNet Selling
ZTS
ZOETIS INC
$69.60B447,791,91793.07%5.75%Net SellingNet Selling
NBIX
NEUROCRINE BIOSCIENCES INC
$10.69B99,703,52770.19%29.81%Net SellingNet Selling
EBS
EMERGENT BIOSOLUTIONS INC
$296.14M54,337,02641.15%58.85%Net SellingNet Selling
LNTH
LANTHEUS HOLDINGS INC
$7.12B68,476,57555.45%44.55%Net SellingNet Selling
TKNO
ALPHA TEKNOVA INC
$356.42M53,436,80611.93%63.98%Net Buying
HROW
HARROW INC
$879.59M35,654,17128.51%71.49%Net SellingNet Selling
ASRT
ASSERTIO HOLDINGS INC
$63.11M95,773,08329.16%20.87%Net BuyingNet Selling
ACB
AURORA CANNABIS INC
$254.63M54,877,9058.84%0.00%
AVDL
AVADEL PHARMACEUTICALS PLC
$831.98M96,629,43582.18%13.63%Net Buying
ELAN
ELANCO ANIMAL HEALTH INC
$4.82B494,613,94090.49%9.51%Net SellingNet Selling
ALVO
ALVOTECH
$2.37B301,805,6775.10%0.00%
ESPR
ESPERION THERAPEUTICS INC
$189.93M197,848,88663.68%20.67%Net SellingNet Selling
SIGA
SIGA TECHNOLOGIES INC
$411.48M71,436,92735.77%64.23%Net SellingNet Selling
VTRS
VIATRIS INC
$9.96B1,193,688,74982.37%17.63%Net SellingNet Selling
CRON
CRONOS GROUP INC
$707.68M382,530,78011.34%49.08%Net SellingNet Selling
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$17.67B1,133,838,68958.60%0.82%Net SellingNet Selling
RDY
DR REDDYS LABORATORIES LTD
$11.63B834,091,33014.20%0.00%
EVO
EVOTEC SE
$1.52B177,553,4565.00%0.00%
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$411.21M13,012,8660.24%0.00%
AMPH
AMPHASTAR PHARMACEUTICALS INC
$1.17B47,650,12150.42%49.58%Net BuyingNet Buying
CPHI
CHINA PHARMA HOLDINGS INC
$6.26M3,261,9110.33%99.67%
TAK
TAKEDA PHARMACEUTICAL CO LTD
$48.44B1,585,179,2494.54%0.00%
RMTI
ROCKWELL MEDICAL INC
$37.46M34,056,92018.89%81.11%Net BuyingNet Buying
KALA
KALA BIO INC
$27.42M6,452,3986.44%93.56%Net Buying
OGI
ORGANIGRAM HOLDINGS INC
$143.82M126,156,6735.60%0.00%
CGC
CANOPY GROWTH CORP
$204.50M147,120,0886.01%72.04%Net SellingNet Selling
BIOA
BIOAGE LABS INC
$155.23M35,850,03754.78%24.78%Net Buying
CRDL
CARDIOL THERAPEUTICS INC
$95.00M82,608,9929.06%0.00%
QNTM
QUANTUM BIOPHARMA LTD
$15.75M2,299,5023.03%0.00%
SBFM
SUNSHINE BIOPHARMA INC
$3.76M2,707,5410.51%99.49%
LFCR
LIFECORE BIOMEDICAL INC
$235.48M37,025,33149.98%50.02%Net Buying
UPC
UNIVERSE PHARMACEUTICALS INC
$26.62k6,077100.00%0.00%
AQST
AQUESTIVE THERAPEUTICS INC
$280.30M98,871,36943.87%7.62%Net SellingNet Selling
PRFX
PAINREFORM LTD
$3.59M1,471,4122.95%0.00%
GELS
GELTEQ LTD
$19.54M9,438,0750.86%0.00%
FLGC
FLORA GROWTH CORP
$11.66M19,435,6422.83%48.46%Net Buying
DRRX
DURECT CORP
$19.25M31,041,9818.92%91.08%
BFRI
BIOFRONTERA INC
$6.48M8,873,93218.17%81.83%
AYTU
AYTU BIOPHARMA INC
$6.60M6,169,8485.97%94.03%Net BuyingNet Buying
EVOK
EVOKE PHARMA INC
$4.02M1,492,8581.82%98.18%Net BuyingNet Buying
IMCC
IM CANNABIS CORP
$4.63M3,085,4523.91%0.00%
SXTC
CHINA SXT PHARMACEUTICALS INC
$8.59M3,906,4710.27%0.00%
IXHL
INCANNEX HEALTHCARE INC
$2.71M17,859,7081.89%25.46%
CTOR
CITIUS ONCOLOGY INC
$63.97M71,552,4020.28%96.54%
RDHL
REDHILL BIOPHARMA LTD
$0.0012,899,831,0000.00%0.00%
TLPH
TALPHERA INC
$8.26M17,098,3458.68%91.32%Net BuyingNet Buying
TLRY
TILRAY BRANDS INC
$493.18M1,006,495,9269.93%1.77%Net Buying
YCBD
CBDMD INC
$1.55M6,262,8330.46%99.54%
TXMD
THERAPEUTICSMD INC
$14.24M11,574,3623.85%96.15%Net BuyingNet Buying
BGM
BGM GROUP LTD
$82.02M7,226,4800.06%0.00%
PTPI
PETROS PHARMACEUTICALS INC
$695.75k53,519,0450.18%14.65%
OPTN
OPTINOSE INC
$93.87M10,072,25918.16%81.84%Net SellingNet Selling
SCYX
SCYNEXIS INC
$38.59M38,981,06431.00%22.75%Net BuyingNet Buying
AKAN
AKANDA CORP
$1.57M1,297,3431.15%0.00%
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$1.19M4,076,5673.62%96.38%Net Selling
INCR
INTERCURE LTD
$69.27M45,572,6895.50%0.00%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Amneal Pharmaceuticals (NASDAQ:AMRX)


Amneal Pharmaceuticals (NASDAQ:AMRX) is the #1 top pharmaceutical stock out of 78 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: C, and AI: B.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 14, which is -13 points lower than the pharmaceutical industry average of 27. Although this number is below the industry average, our proven quant model rates AMRX as a "A".

AMRX passed 5 out of 33 due diligence checks and has weak fundamentals. Amneal Pharmaceuticals has seen its stock return 30.47% over the past year, overperforming other pharmaceutical stocks by 89 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $11.33, an upside of 46.23% from Amneal Pharmaceuticals's current stock price of $7.75.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Supernus Pharmaceuticals (NASDAQ:SUPN)


Supernus Pharmaceuticals (NASDAQ:SUPN) is the #2 top pharmaceutical stock out of 78 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Supernus Pharmaceuticals (NASDAQ:SUPN) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: B.

Supernus Pharmaceuticals (NASDAQ:SUPN) has a Due Diligence Score of 58, which is 31 points higher than the pharmaceutical industry average of 27.

SUPN passed 18 out of 33 due diligence checks and has strong fundamentals. Supernus Pharmaceuticals has seen its stock return 6.18% over the past year, overperforming other pharmaceutical stocks by 65 percentage points.

Supernus Pharmaceuticals has an average 1 year price target of $36.00, an upside of 10.8% from Supernus Pharmaceuticals's current stock price of $32.49.

Supernus Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Supernus Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the #3 top pharmaceutical stock out of 78 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pacira Biosciences (NASDAQ:PCRX) is: Value: B, Growth: B, Momentum: C, Sentiment: C, Safety: B, Financials: B, and AI: C.

Pacira Biosciences (NASDAQ:PCRX) has a Due Diligence Score of 23, which is -4 points lower than the pharmaceutical industry average of 27. Although this number is below the industry average, our proven quant model rates PCRX as a "A".

PCRX passed 7 out of 33 due diligence checks and has weak fundamentals. Pacira Biosciences has seen its stock return 3.65% over the past year, overperforming other pharmaceutical stocks by 63 percentage points.

Pacira Biosciences has an average 1 year price target of $32.80, an upside of 21.48% from Pacira Biosciences's current stock price of $27.00.

Pacira Biosciences stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Pacira Biosciences, 20% have issued a Strong Buy rating, 40% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.42%, which is 7 percentage points higher than the pharmaceutical industry average of 3.43%.

Siga Technologies's dividend payout ratio of 72.3% indicates that its high dividend yield is sustainable for the long-term.

2. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 3.29%, which is the same as the pharmaceutical industry average of 3.43%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -88.6% indicates that its dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) has an annual dividend yield of 3.03%, which is the same as the pharmaceutical industry average of 3.43%.

Kamada's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.5% in the last day, and up 4.85% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Bausch Health Companies (NYSE:BHC)


Bausch Health Companies (NYSE:BHC) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 0, which is -15 points higher than the pharmaceutical industry average of 15. It passed 0 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates BHC a Valuation Rating of "A".

Bausch Health Companies's stock has dropped -37.95% in the past year. It has overperformed other stocks in the pharmaceutical industry by 21 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 14, which is -1 points higher than the pharmaceutical industry average of 15. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates IRWD a Valuation Rating of "A".

Ironwood Pharmaceuticals's stock has dropped -88.07% in the past year. It has underperformed other stocks in the pharmaceutical industry by -29 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Collegium Pharmaceutical has a valuation score of 57, which is 42 points higher than the pharmaceutical industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has dropped -24.82% in the past year. It has overperformed other stocks in the pharmaceutical industry by 34 percentage points.

Are pharmaceutical stocks a good buy now?

47.62% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 47.5% over the next year.

10.71% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 17.86% of pharmaceutical stocks are rated B (Buy), 53.57% are rated C (Hold), 12.5% are rated D (Sell), and 5.36% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 21.8x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.